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Abstract
Background: Methylation of cytosine in genomic DNA is a well-characterized epigenetic modification involved in
many cellular processes and diseases. Whole-genome bisulfite sequencing (WGBS), such as MethylC-seq and post-
bisulfite adaptor tagging sequencing (PBAT-seq), uses the power of high-throughput DNA sequencers and provides
genome-wide DNA methylation profiles at single-base resolution. However, the accuracy and consistency of WGBS
outputs in relation to the operating conditions of high-throughput sequencers have not been explored.
Results: We have used the Illumina HiSeq platform for our PBAT-based WGBS, and found that different versions of
HiSeq Control Software (HCS) and Real-Time Analysis (RTA) installed on the system provided different global CpG
methylation levels (approximately 5% overall difference) for the same libraries. This problem was reproduced multiple
times with different WGBS libraries and likely to be associated with the low sequence diversity of bisulfite-converted
DNA. We found that HCS was the major determinant in the observed differences. To determine which version of
HCS is most suitable for WGBS, we used substrates with predetermined CpG methylation levels, and found that HCS
v2.0.5 is the best among the examined versions. HCS v2.0.12 showed the poorest performance and provided artificially
lower CpG methylation levels when 5-methylcytosine is read as guanine (first read of PBAT-seq and second read of
MethylC-seq). In addition, paired-end sequencing of low diversity libraries using HCS v2.2.38 or the latest HCS v2.2.58
was greatly affected by cluster densities.
Conclusions: Software updates in the Illumina HiSeq platform can affect the outputs from low-diversity sequencing
libraries such as WGBS libraries. More recent versions are not necessarily the better, and HCS v2.0.5 is currently the best
for WGBS among the examined HCS versions. Thus, together with other experimental conditions, special care has to be
taken on this point when CpG methylation levels are to be compared between different samples by WGBS.
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Background
Methylation of cytosine (C) in genomic DNA is a well-
characterized epigenetic modification involved in many
cellular processes, including differentiation, genomic
imprinting, X-chromosome inactivation, transposon
silencing, chromosome stability, and maintenance of
homeostasis. Aberrant DNA methylation has been reported
in a growing number of human diseases, such as cancer,
developmental diseases, and metabolic disorders [1]. Until
a decade ago, DNA methylation studies only focused on
small regions of the genome because of technical limi-
tations. However, recent advances in DNA sequencing
technology has made it possible to construct single-
base resolution maps of 5-methylcytosine (5mC) at the
genome-wide scale [2]. The technology is collectively
called whole-genome bisulfite sequencing (WGBS) or
methylome analysis, and its practical methods include
MethylC-seq [3] and post-bisulfite adaptor tagging
sequencing (PBAT-seq) [4]. Reduced representation
bisulfite sequencing (RRBS) is also used for single-base
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resolution 5mC mapping in CpG-rich regions of the gen-
ome [5]. The first complete methylome maps were con-
structed by MethylC-seq [6–8], and then the PBAT method
was developed for performing amplification-free WGBS of
a nanogram quantity of DNA [4]. With this method,
methylome maps were constructed for human and mouse
cells [9–15] as well as plant and fungal cells [4, 16]. WGBS
is increasingly important in biology and medicine and the
International Human Epigenome Consortium (IHEC) rec-
ommends WGBS as the standard method for DNA methy-
lation analysis (http://ihec-epigenomes.org/).
The Illumina HiSeq platform accounts for the majority
of WGBS studies that are currently under way because
this technology generates the largest amount of data per
run at the lowest cost per base among the high-throughput
sequencers [2, 17]. Like many other laboratories, we have
been using the HiSeq platform for our PBAT-based WGBS.
In the base calling system of HiSeq, the HiSeq Control Soft-
ware (HCS) locates clusters, extracts intensity, and calcu-
lates color matrix before the Real-Time Analysis (RTA)
performs base calling and quality scoring (Additional file 1:
Figure S1a). Accurate base calling requires sequence
diversity because identification of individual clusters
and determination of their coordinates by HCS relies
on the diversity. Thus, low sequence diversity samples,
including bisulfite-converted DNAs, are obviously not
the best substrates for HiSeq sequencing [18].
In the course of our WGBS study on mouse spermato-
gonia [13], we realized that different versions of HCS and
RTA installed on the HiSeq system provided different
global CpG methylation levels (approximately 5% differ-
ence) for the same libraries. This problem was reproduced
in our system using different WGBS libraries and also in
HiSeq systems of other laboratories. We found that the first
read of PBAT-seq and the second read of MethylC-seq
were affected. Thus, it appeared that the problem resides in
inaccurate calling of guanine (G), which appears at the pos-
ition corresponding to 5mC in the complementary strand.
These and other observations suggest that software updates
can affect the sequence outputs from low diversity libraries
such as WGBS libraries. Here we describe the details of the
problem, determine which versions of HCS and RTA
are more reliable, and discuss our recommendations to
minimize the problem.
Results and discussion
Different HCS and RTA versions provide different CpG
methylation levels
WGBS relies on bisulfite conversion of unmethylated C,
but not 5mC, to uracil. Because 5mC normally occupies
only a small proportion of Cs, bisulfite-treated DNA shows
depletion of C, resulting in a low diversity sequence. PBAT-
seq is designed to generate sequence reads complementary
to the bisulfite-converted strand, and thus 5mC appears as
G in the first read (R1) and as C in the second read (R2)
(Additional file 1: Figure S1b) [4]. In the course of our
WGBS study of early postnatal mouse spermatogonia [13],
we realized that the global CpG methylation level deter-
mined by PBAT-seq of the same library significantly chan-
ged upon HCS and RTA updates of the HiSeq sequencer.
Therefore, we set out to examine the generality of the prob-
lem and to explore the causes. Throughout this paper,
global CpG methylation levels refer to weighted levels,
which take sequencing depth into account [19].
We performed a series of single-end runs using three
PBAT libraries (IMR-90 human fibroblasts, mouse epiblast-
like cells [EpiLCs], and mouse spermatogonia). Each library
was sequenced multiple times (replicates) and each repli-
cate run was performed using a lane of flow cell on a HiSeq
1500 or HiSeq 2500 sequencers (Additional file 1:
Figure S1c). We mapped single-end sequence reads
trimmed to 96 bases on the human (hg19) or the mouse
(mm10) reference genome and obtained 59–99 million
uniquely mapped reads per lane (Additional file 1: Table S1).
We confirmed that different combinations of HCS and RTA
versions provided different global CpG methylation
levels (up to approximately 5% difference) for the same
libraries (Fig. 1a, b, Additional file 1: Figure S2a). Such
differences were observed even when an identical HiSeq
sequencer was used (Additional file 1: Figure S1d). The
global CpG methylation difference of 5% was not negli-
gible because similar differences were observed in several
types of mouse cells during differentiation (Additional file 1:
Figure S3).
For the three libraries, HCS v2.0.5 always provided the
highest CpG methylation level, and HCS v2.0.12 the
lowest (Fig. 1a). Compared with the other HCS versions,
HCS v2.0.12 provided less Gs (Fig. 1a), indicating that a
decreased G count is the cause of the lower methylation
levels. HCS v2.0.10 provided a methylation level ap-
proximately 5% higher than that obtained by HCS
v2.0.12, even though the same RTA version (v1.17.21.3)
was used (Fig. 1b, Additional file 1: Figure S2b). Thus,
HCS and not RTA was the major determinant of the ob-
served differences. Regions with higher CpG density
tended to show larger differences between HCS v2.0.5
and v2.0.12 (Fig. 1c, Additional file 1: Figure S2c). Fur-
thermore, when we tried to identify partially methylated
domains (PMDs) in EpiLCs, the two versions gave very
different results (Additional file 1: Figure S2d). The
PMDs are observed in several cell types including cancer
cells [20] and associated with intermediate levels of
methylation, specific histone modifications, nuclear lam-
ina, and gene silencing [21, 22], showing that different
HCS versions can impact biological outcomes.
We next prepared a paired-end PBAT library from
IMR-90 human fibroblasts and compared the results ob-
tained using the three HCS versions (Additional file 1:
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Table S1). As mentioned above, 5mC appears as G in R1
and as C in R2 in paired-end PBAT-seq (Additional file 1:
Figure S1b). R1 data showed CpG methylation differences
with different HCS versions (Fig. 1d), similar to those ob-
served by single-end PBAT-seq (Fig. 1a). Interestingly, R2
data showed smaller differences (<1.0%) (Fig. 1d). Thus,
R1 data derived by HCS v2.0.12 produced a significantly
lower (approximately 4%) methylation level than the cor-
responding R2 data (Fig. 1d). Ideally, R1 and R2 data
should provide identical methylation levels. Among the
HCS versions, v2.0.5 produced the closest R1 and R2
methylation levels (Fig. 1d).
We previously performed paired-end MethylC-seq
with human genomic DNA (purchased from Promega)
using HCS v2.0.12 and RTA v1.17.21.3 (accession no.
DRA002280) [14]. MethylC-seq is designed to read
5mC as C in R1 and as G in R2 [3], which is the
opposite of PBAT-seq. The global CpG methylation
level determined using R2 data (55.5%) was lower than
that determined using R1 data (57.4%) as expected.
However, the difference between R1 and R2 methyla-
tion levels was relatively small (1.9%) compared with
the other paired-end WGBS cases. We then realized
that this particular paired-end MethylC-seq library
had contained unconverted PhiX DNA at 50% w/w.
Thus, the 50% w/w PhiX DNA spike-in may have alle-
viated the problem, perhaps through increasing the
sequence diversity, for this run using HCS v2.0.12.
These results suggest that R1 of PBAT-seq and R2 of
MethylC-seq provide lower methylation levels than
the other reads and that the methylation level is lower
when 5mC is read as G or is higher when 5mC is read
as C.
The HCS version suitable for WGBS
We then attempted to determine which version of HCS
is most suitable for WGBS. To generate substrates with
known CpG methylation levels, lambda phage DNA was
methylated in vitro to near completion by treatment
with SssI methyltransferase. We confirmed the overall
Fig. 1 Different CpG methylation levels obtained from identical PBAT libraries using different HCS and RTA versions. a CpG methylation levels determined
by single-end PBAT-seq. CpG methylation levels in 100 kb windows are shown as a box plot (left). Different proportions of G among the four bases in R1
obtained using different HCS and RTA versions are shown as a line plot (right). b Correlation between the CpG methylation levels determined using HCS
v2.0.5, v2.0.10, and v2.0.12. CpG methylation values of 100-kb non-overlapping sliding windows across the autosomes are plotted with a linear regression
line (red). c Differences between the CpG methylation levels determined using HCS v2.0.5 and v2.0.12 against the CpG density. CpG methylation values
were calculated in 100-kb non-overlapping sliding windows across the autosomes. All 100 kb windows were grouped into nine classes according to the
number of contained CpG. d CpG methylation levels determined by paired-end PBAT-seq (IMR-90). CpG methylation levels in 100 kb windows are
shown as a box plot (left). Different proportions of G in R1 and C in R2 obtained using different HCS and RTA versions are shown as a line plot (right)
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resistance of the treated DNA to methylation-sensitive
restriction enzyme HpaII (data not shown). Furthermore,
we performed bisulfite sequencing at three loci (58 CpG
sites), which demonstrated 97.9% CpG methylation
(Additional file 1: Figure S4). We prepared a series of
lambda DNA mixtures with increasing proportions of
the methylated DNA (10, 44, and 88%) and performed
paired-end PBAT-seq using the three HCS versions. We
mapped the reads onto the lambda phage genome
(48,502 base pairs) and obtained 3.5–8.0 million uniquely
mapped reads (Additional file 1: Table S2), with the calcu-
lated average depths of 3,498–7,962 per strand. R1 data
revealed striking differences in CpG methylation between
the HCS versions, with HCS v2.0.5 showing the best per-
formance (closest to the predetermined level) and v2.0.12
the poorest (Fig. 2a). In contrast, R2 data showed smaller
differences, and all data were close to the predetermined
level (Fig. 2a). HCS v2.0.5 provided the least differences
between R1 and R2 methylation levels (Fig. 2b), consistent
with the findings in human and mouse genomic DNAs
(Fig. 1d). HCS v2.0.12 always provided the lowest methyla-
tion levels in R1 among the different versions (Figs. 1a, d,
and 2a). These results indicate that HCS v2.0.5 is most
suitable for WGBS among the three HCS versions and
that HCS v2.0.12 provides methylation levels lower than
the real values when 5mC is read as G. Since R2 data ob-
tained with different HCS versions were all close to the
real values, single-end MethylC-seq, where 5mC is read as
C, should not be affected by the versions.
Quality scores assigned to 5mCs
Next, we examined the quality scores assigned to the
respective bases of the PBAT-seq reads. In the single-end
PBAT-seq data obtained from IMR-90 human fibroblasts,
mouse EpiLCs, and mouse spermatogonia, quality
scores over 30 (99.9% accuracy) were assigned to over
85% of the bases other than G (Additional file 1: Figure S5).
However, the quality scores assigned to G greatly changed
depending on the HCS versions. In particular, HCS v2.0.12
assigned low quality scores to G (only 18–36% of G had
quality scores over 30) (Fig. 3a). Steep drops (>10) in quality
score were observed at Gs in 78.0% of the sequence reads
containing at least one G (IMR-90) (Fig. 3b). In contrast,
high quality scores were consistently observed at Gs in the
unconverted PhiX phage control lane of the same flow cell
(Fig. 3b). HCS v2.0.10 assigned better quality scores to Gs
than HCS v2.0.12 with the same RTA version (v1.17.21.3)
(Fig. 3a). We did not find low score assignments to Gs in
our PBAT-seq data generated using earlier HCS ver-
sions, including HCS v1.5.15, v1.4.8, and v1.1.37 (data
not shown), suggesting that HCS v1 may not have the
problem in G calling.
In the paired-end PBAT-seq using HCS v2.0.12 (IMR-90),
Gs in R1 showed lower quality scores than Cs in R2
(Fig. 3c). In contrast, in the paired-end MethylC-seq using
HCS v2.0.12 (accession no. DRA002280) [14], Gs in R2 had
lower quality scores than Cs in R1, even though PhiX DNA
was added at 50% w/w to confer sufficient sequence diver-
sity (Fig. 3c). These results showed that HCS v2.0.12 has
problems in scoring the fewest G bases in low diversity
samples showing depletion of Gs. The low quality scores
and fewer G outputs may be linked to each other, and both
are likely due to the fact that base G has the lowest fluores-
cence intensity among the four bases [23].
Effect of cluster density on WGBS
The identification of individual clusters and determination
of their coordinates by HCS relies on sequence diversity
Fig. 2 Observed versus predetermined CpG methylation levels of a series of mixture of unmethylated and in vitro methylated lambda DNAs. a
The differences between the observed and predetermined CpG methylation levels are plotted against the predetermined CpG methylation levels
for each HCS version. R1 and R2 data from paired-end PBAT-seq runs were separately analyzed. b Differences between the R1 and R2 CpG methylation
levels are shown for each HCS version
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because discrimination of clusters in close proximity re-
quires different fluorescence signals in the initial cycles.
Thus, it has been reported that low diversity sequencing is
affected in a high cluster density range [18]. To investigate
the relationships between cluster density, HCS version,
and CpG methylation level in WGBS, we prepared a series
of dilutions of the paired-end PBAT library (IMR-90),
loaded them onto flow cell lanes, and created different
cluster densities (323–629 K per mm2; recommended
range for v3 cluster kits 750–850 K per mm2) (Additional
file 1: Table S3). The three HCS versions provided similar
CpG methylation levels (<0.5% difference) at different
cluster densities (Additional file 1: Table S3), indicating
that lower cluster densities have little impact in this case.
However, HCS v2.2.38 assigned lower quality scores to
Cs in R2, as the cluster density increases (Fig. 4a). Such a
density-dependent decrease in quality score for C was not
observed with the other HCS versions (v2.0.5 and v.2.0.12)
(Fig. 4b). Also, Gs of R1 of the same sequencing run did
not show such drops in quality score (data not shown).
Because the PhiX control at a high cluster density (672 K
per mm2) showed good quality scores at Cs in R2 (Fig. 4a),
we speculate that HCS v2.2.38 provides lower quality
scores to the fewest bases in low-diversity R2 data. Fur-
thermore, R2 data generated using HCS v2.2.38 at 629 K
per mm2 provided a high global non-CpG (CpA, CpT, and
CpC) methylation level (1.86%) for IMR-90 human fibro-
blasts, which is clearly different from other data (<0.1%)
[24], suggesting that R2 data may be less accurate.
Recently, HCS v2.2.58 and RTA v1.18.64 were re-
leased from Illumina. To examine the performance of
the latest versions, we performed paired-end PBAT-seq
on an IMR-90 library constructed from the same DNA
as the above studies (Additional file 1: Table S3). These
versions provided a global CpG methylation level simi-
lar to that obtained by HCS v2.0.5 (62.4% versus 63.0%)
in R1. However, they assigned very low quality scores
to overall R2 data at a modest cluster density (483 K
per mm2) (Fig. 4c) and quality scores over 30 were
assigned to only 1.8% of all bases.
Fig. 3 Quality scores assigned to base G. a Quality scores assigned to Gs in the raw reads obtained using different HCS versions. All Gs were
grouped into four classes according to the assigned quality score. b Examples of drops in quality score at Gs. Representative sequence reads
from the PBAT-seq (IMR-90) and control (PhiX) data generated using HCS v2.0.12 are shown. Gs in the IMR-90 read are shown in red. c Quality
scores assigned to the base representing 5mC (G or C) in R1 and R2 of the paired-end PBAT-seq and MethylC-seq using HCS v2.0.12. In the
MethylC-seq, 50% w/w PhiX DNA was spiked in (accession no. DRA002280) [14]
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WGBS data generated by new Illumina systems
Finally, we analyzed published paired-end WGBS data gen-
erated by new Illumina systems, HiSeq 4000 and NextSeq
500. HCS v3.3.x is installed on HiSeq 4000, which uses pat-
terned flow cell technology. We analyzed MethylC-seq data
(GSM1707686 and GSM2137773) generated by HiSeq
4000 and found that the difference between R1 and R2
global CpG methylation levels was 2.3% in both data sets.
As expected, R1 produced a higher methylation level than
corresponding R2 (Additional file 1: Figure S6a). Quality
scores over 30 were assigned to approximately 50% of the
Gs in R2 (Additional file 1: Figure S6a). Thus, the perform-
ance of HiSeq 4000 seemed better than HCS v.2.0.12, but it
was not clear whether its performance was better than
HCS v2.0.5.
We also analyzed MethylC-seq data (GSM1973803 and
GSM1973807) generated by NextSeq 500, which uses a
two-color chemistry. Calls for G are made where there is
actually no signal on a flow cell. In this run, 30% PhiX
DNA was spiked in [25]. We found that the differ-
ence between R1 and R2 global CpG methylation levels
was relatively small (1.9 and 0.6%) (Additional file 1:
Figure S6b). Quality scores over 30 were assigned to
73% of the Gs in R2 (Additional file 1: Figure S6b).
Taken together, WGBS outputs by HiSeq 4000 and
NextSeq 500 produced better results than HCS v2.0.12.
Since we had no information on the software versions
and cluster densities, further validation requires repli-
cates from the same WGBS libraries.
Conclusions
In this study, we found the following regarding the use
of Illumina HiSeq sequencers for WGBS. (1) HCS v2.0.5
is currently the best HCS version among the HCS v2 for
WGBS (both single-end and paired-end). This version
provides CpG methylation levels closest to the real
values. (2) It is better to avoid using HCS v2.0.12 for
WGBS. This version provides methylation levels lower
than the real values (up to approximately 5% difference)
and assigns very low quality scores to G bases. (3) R2 of
paired-end sequencing of low diversity libraries using
HCS v2.2.38 or the latest HCS v2.2.58 is greatly affected
by cluster densities. Thus, when using HCS v2.2.38 or
v2.2.58, it is better to choose single-end sequencing.
Based on these findings, we suggest the following for
WGBS using the HiSeq platform. (1) The same HCS
Fig. 4 Effect of cluster density on paired-end PBAT-seq (IMR-90). a Quality scores assigned to the four bases in R2 generated using HCS v2.2.38 at
different cluster densities. The quality scores in R2 of PhiX control on the same flow cell are also shown. b Quality scores assigned to Cs in R2
generated using different HCS versions at different cluster densities. c Quality scores assigned to the four bases in R1 and R2 generated using the
latest HCS v2.2.58 at a modest cluster density (483 K per mm2). The quality scores in R2 of PhiX control on the same flow cell are also shown
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version should be used for data comparisons, whenever
possible. (2) Avoid using protocols that read 5mC as G,
whenever possible. Choose single-end (not paired-end)
sequencing for MethylC-seq and RRBS. We are currently
developing a single-end PBAT protocol where 5mC can
be represented by C. Addition of 50% w/w PhiX DNA
may alleviate the problem, but not fully. (3) Check the
quality scores of 5mC in each read. Data showing lower
quality scores at 5mC appear to be less accurate, even if
its overall quality score is high. (4) Describe the versions
of HCS and RTA when publishing WGBS results. It is
also helpful to provide the information as metadata in
databases. This will help the users to judge whether they
can be used for comparison.
Methods
Biological materials
Mouse genomic DNA (C57BL/6) was isolated as previously
described [13]. IMR-90, a human fibroblast cell line, was
cultured as previously described [26].
Methylation of lambda DNA
To generate methylated control DNA, 1 μg of lambda
phage DNA (Promega) was methylated with CpG
methyltransferase SssI (New England BioLabs) for 3 h
at 37 °C. Near complete methylation was confirmed by
the resistance to methylation-sensitive restriction en-
zyme HpaII (New England BioLabs). Then, 100 ng of the
DNA was bisulfite converted and three lambda loci were
amplified by polymerase chain reaction (PCR) (95 °C for
30 s followed by 15 cycles of 95 °C for 30 s, 61 °C for 30 s,
and 72 °C for 30 s). The PCR products were cloned into
pMD20 (TaKaRa) and sequenced. This analysis demon-
strated a 97.9% CpG methylation level (Additional file 1:
Figure S4). The PCR primers used are listed in Additional
file 1: Table S4.
Preparation of the PBAT library
DNAs samples were subjected to bisulfite treatment with
the EZ DNA Methylation-Gold Kit (Zymo Research).
PBAT libraries were constructed as described [4], using a
new second-strand-synthesis primer: 5′-CAA GCA GAA
GAC GGC ATA CGA GAT XXX XXX GTA AAA CGA
CGG CCA GCA GGA AAC AGC TAT GAC NNN N-3′
(XXX XXX indicate the sample specific Illumina index tag).
Concentrations of the PBAT products were quantified
using the KAPA Illumina Library Quantification Kit (Kapa
Biosystems).
Illumina HiSeq sequencing and data analysis
The libraries were sequenced on a HiSeq 2500 or a
HiSeq 1500 sequencer to generate 101-nt single-end
or paired-end reads. Cluster generation and sequen-
cing were performed in a single-read mode using the
TruSeq SR/PE Cluster Kit v3-cBot-HS (Illumina) and
TruSeq SBS Kit v3-HS (Illumina) according to the
manufacturer’s protocols. In all runs, one of the eight
lanes (lane 5) on a flow cell was used as a dedicated
control lane (PhiX) for matrix and phasing calcula-
tions (cluster density 290–717 K per mm2). To avoid
potential lane-specific effects, we used the same lane
for the same library in all paired-end runs. We truncated
raw sequence reads to 96 bases to remove the remaining
adapter sequences from the 5′ end and one base from the
3′ end. The resulting reads were aligned to the reference
human genome (hg19), mouse genome (mm10), or lambda
genome (accession no. J02459) using Bismark v0.10.0 [27].
We used parameters of 28 for the seed length, 1 for the
maximum number of mismatches permitted in the seed,
and the option “–pbat” that works for PBAT libraries. Only
uniquely aligned reads were analyzed.
Identification of PMDs
We used a sliding window approach to find PMDs, as
described previously [8]. First, each chromosome is
divided into 10 kb non-overlapping windows. When a
10-kb window contained ten or more CpG sites, each
of which were covered at least once, the CpG methyla-
tion level of the window was calculated. When the
CpG methylation level of the 10-kb window was less
than 70%, the window was defined as a PMD window.
Contiguous PMD windows were collapsed into a sin-
gle PMD, and then only those longer than 100 kb were
picked up in this study.
Additional file
Additional file 1: Table S1. Summary of PBAT-seq with human and
mouse genomic DNA using different HCS and RTA versions. Table S2.
Summary of PBAT-seq with in vitro methylated lambda phage DNA.
Table S3. Summary of the effect of cluster density on PBAT-seq using
different HCS versions. Table S4. Bisulfite PCR primers for lambda
DNA. Figure S1. Experimental design to investigate the effect of HCS
and RTA updates. Figure S2. Different CpG methylation levels obtained for
identical PBAT libraries using different HCS and RTA versions. Figure S3.
Changes in global CpG methylation level during mouse cell differentiation.
Figure S4. Bisulfite sequencing of in vitro CpG methylated lambda DNA at
three selected loci. Figure S5. Quality scores assigned to the four bases.
Figure S6. WGBS data generated by new Illumina systems. (PDF 1211 kb)
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